Transderm Scop (Sandoz Inc)
Welcome to the PulseAid listing for the Transderm Scop drug offered from Sandoz Inc. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | scopolamine |
| SUBSTANCE NAME: | SCOPOLAMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
| ROUTE: | TRANSDERMAL |
| DOSAGE FORM: | PATCH, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-12-01 |
| END MARKETING DATE: | 0000-00-00 |
Transderm Scop HUMAN PRESCRIPTION DRUG Details:
| Item Description | Transderm Scop from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/3d) |
| START MARKETING DATE: | 2016-12-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66758-208_7feaf7c2-2c08-4b0d-bedf-bdec7507b390 |
| PRODUCT NDC: | 66758-208 |
| APPLICATION NUMBER: | NDA017874 |
Other SCOPOLAMINE Pharmaceutical Manufacturers / Labelers:
